Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol-Reference-Cited by-同舟云学术

Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol

Published:2021-06 Issue:6 Volume:10 Page:622-632
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Macwan Joyce S.¹,Fraczkiewicz Grace¹,Bertolino Mauro²,Krüger Phillip³,Peters Sheila‐Annie²

Affiliation:

1. Simulations Plus, Inc Lancaster California USA

2. Quantitative Pharmacology Merck KGaA Darmstadt Germany

3. Manufacturing Science and Technology Merck KGaA Darmstadt Germany

Funder

Merck KGaA

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12634

Reference31 articles.

1. US Food and Drug Administration.Impact story: modeling tools could modernize generic drug development.https://www.fda.gov/drugs/regulatory‐science‐action/impact‐story‐modeling‐tools‐could‐modernize‐generic‐drug‐development. Accessed July 19 2020.

2. Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report

3. Basic Pharmacokinetics of Bisoprolol, a New Highly Beta1-selective Adrenoceptor Antagonist

4. Balanced pharmacokinetics and metabolism of bisoprolol;Leopold G;J Cardiovasc Pharmacol,1986

5. Bisoprolol in Angina Pectoris

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous Manufacturing of Solvent-Free Cyclodextrin Inclusion Complexes for Enhanced Drug Solubility via Hot-Melt Extrusion: A Quality by Design Approach;Pharmaceutics;2023-08-25

2. Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space;Journal of Pharmaceutical Sciences;2023-07

3. Approaches of formulation bridging in support of orally administered drug product development;International Journal of Pharmaceutics;2022-12

4. Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs;Pharmaceutical Research;2022-07-15

5. A Novel Approach to Justify Dissolution Differences in an Extended Release Drug Product using Physiologically Based Biopharmaceutics Modeling and Simulation;Journal of Pharmaceutical Sciences;2022-06